Press Release | NeoGenomics Laboratories

November 4, 2021

NeoGenomics Reports Revenue of $121 Million in the Third Quarter

October 19, 2021

NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays

September 9, 2021

NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR™ MRD and InVisionFirst®-Lung Assays at the ESMO Congress 2021

September 1, 2021

NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

September 1, 2021

NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

July 14, 2021

NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021

June 18, 2021

NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

May 27, 2021

NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients